Sectors
TELO
Telomir Pharmaceuticals, Inc.
1.12
2 x 0.80
2 x 1.40
bid
ask
-
0.02
1.75%
2 @ 05:54 PM
1.17 +0.05 (4.46%)
| Ytd | -15.79% | |
| 1y | -15.15% |
1.08
day range
1.14
0.89
52 week range
2.09
| Open | 1.11 | Prev Close | 1.14 | Low | 1.08 | High | 1.14 | Mkt Cap | 77.03M |
| Vol | 45.35K | Avg Vol | 99.70K | EPS | -1.11 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.24 | Short Ratio | 5.77 | Inst. Own | 6.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 1.19 | 200-d Avg | 1.28 | 1yr Est | 12.15 |
| Income Statement | |||
| Operating Expenses | 1.76M | ||
| Research and Development Expense | 444.67K | ||
| Selling, General and Administrative Expense | 1.32M | ||
| Operating Income | -1.76M | ||
| Interest Expense | 3.03K | ||
| Net Income | -1.72M | ||
| Net Income Common Stock | -47.84M | ||
| Net Income Common Stock (USD) | -47.84M | ||
| Consolidated Income | -1.72M | ||
| Earnings per Basic Share | -0.79 | ||
| Earnings per Basic Share (USD) | -0.79 | ||
| Earnings per Diluted Share | -0.79 | ||
| Earning Before Interest & Taxes (EBIT) | -1.72M | ||
| Earning Before Interest & Taxes (USD) | -1.72M | ||
| Preferred Dividends Income Statement Impact | 46.11M | ||
| Weighted Average Shares | 60.84M | ||
| Weighted Average Shares Diluted | 60.84M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.17M | ||
| Cash and Equivalents (USD) | 5.17M | ||
| Current Assets | 5.37M | ||
| Total Assets | 5.37M | ||
| Debt Current | 136.37K | ||
| Total Debt | 136.37K | ||
| Current Liabilities | 332.42K | ||
| Total Liabilities | 332.42K | ||
| Accumulated Retained Earnings (Deficit) | -43.72M | ||
| Shareholders Equity | 5.03M | ||
| Shareholders Equity (USD) | 5.03M | ||
| Total Debt (USD) | 136.37K | ||
| Trade and Non-Trade Payables | 196.05K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 622.11K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -390.22K | ||
| Issuance (Purchase) of Equity Shares | 1.01M | ||
| Issuance (Repayment) of Debt Securities | -384.20K | ||
| Net Cash Flow from Operations | -1.01M | ||
| Share Based Compensation | 786.47K | ||